Brian Aquila - Waltham MA, US Donald J. Cook - Waltham MA, US Craig Johnstone - Macclesfield, GB Stephen Lee - Waltham MA, US Paul Lyne - Waltham MA, US David Alan Rudge - Macclesfield, GB Melissa Vasbinder - Waltham MA, US Haixia Wang - Waltham MA, US
The invention relates to chemical compounds of the formula (I) or pharmaceutically acceptable salts thereof, which possess B-Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
Substituted Heterocycles And Their Use As Chk1, Pdk1 And Pak Inhibitors
Kevin Daly - Waltham MA, US Nicola Heron - Macclesfield, GB Alexander Hird - Waltham MA, US Stephanos Ioannidis - Waltham MA, US James Janetka - Waltham MA, US Paul Lyne - Waltham MA, US Jaime Scott - Macclesfield, GB Dorin Toader - Waltham MA, US Melissa Vasbinder - Waltham MA, US Dingwei Yu - Waltham MA, US Yan Yu - Waltham MA, US
The invention relates to novel compounds of Formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds possess CHK1 kinase inhibitory activity, PDK1 inhibitory activity and Pak kinase inhibitory activity and are accordingly useful in the treatment and/or prophylaxis of cancer.
Targeted Protein Degradation Of Parp14 For Use In Therapy
- Cambridge MA, US Melissa Marie Vasbinder - Newton MA, US Kevin Wayne Kuntz - Woburn MA, US Kerren Kalai Swinger - Lexington MA, US Timothy J.N. Wigle - Cambridge MA, US
International Classification:
C07D 401/14 C07D 417/14 C07D 405/14
Abstract:
The present invention relates to quinazolinones and related compounds which degrade PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.
- Cambridge MA, US Kevin Wayne Kuntz - Cambridge MA, US Laurie B. Schenkel - Cambridge MA, US Kerren Kalai Swinger - Cambridge MA, US Melissa Marie Vasbinder - Cambridge MA, US
International Classification:
A61K 31/517 A61K 45/06 A61P 1/00
Abstract:
The present invention relates to use of quinazolinones and related compounds which are inhibitors of PARP14 for the treatment and prevention of an inflammatory disease.
Quinolines And Azaquinolines As Inhibitors Of Cd38
- Cambridge MA, US Danielle J. Blackwell - Medford MA, US Kevin Wayne Kuntz - Woburn MA, US Melissa Marie Vasbinder - Newton MA, US Laurie B. Schenkel - Somerville MA, US Kerren Kalai Swinger - Lexington MA, US
The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.